First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial

Paz-Ares, Luis ; Ciuleanu, Tudor-Eliade ; Cobo, Manuel ; Schenker, Michael ; Zurawski, Bogdan ; Menezes, Juliana ; Richardet, Eduardo ; Bennouna, Jaafar ; Felip, Enriqueta ; Juan-Vidal, Oscar ; Alexandru, Aurelia ; Sakai, Hiroshi ; Lingua, Alejo ; Salman, Pamela ; Souquet, Pierre-Jean ; De Marchi, Pedro ; Martin, Claudio ; Pérol, Maurice ; Scherpereel, Arnaud ; Lu, Shun ; John, Thomas ; Carbone, David P ; Meadows-Shropshire, Stephanie ; Agrawal, Shruti ; Oukessou, Abderrahim ; Yan, Jinchun ; Reck, Martin

The Lancet (British edition), 2021-02, Vol.22 (2), p.198-211 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível